Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hammers, A.
Right arrow Articles by Duncan, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammers, A.
Right arrow Articles by Duncan, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 124, No. 8, 1555-1565, August 2001
© 2001 Oxford University Press

Central benzodiazepine receptors in malformations of cortical development

A quantitative study

Alexander Hammers1,2, Matthias J. Koepp1,2, Mark P. Richardson1,2, Claire Labbé1, David J. Brooks1, Vincent J. Cunningham1 and John S. Duncan1,2

1 MRC Cyclotron Unit, Clinical Sciences Centre, Hammersmith Hospital and 2 National Society for Epilepsy, Institute of Neurology, London, UK

Correspondence to: Professor John S. Duncan, National Society for Epilepsy and Institute of Neurology, 33 Queen Square, London WC1N 3BG, UK E-mail: j.duncan{at}ion.ucl.ac.uk

We calculated [11C]flumazenil volume of distribution ([11C]FMZ-Vd) after correction for partial volume effect in 10 patients with malformations of cortical development (MCDs) and partial seizures, to quantify the GABAA–central benzodiazepine receptor complex. Abnormal grey matter and adjacent or overlying cortex were outlined individually and added to an individualized anatomical template for correction for partial volume effect. Nine of 10 patients showed single or multiple increases or decreases in [11C]FMZ-Vd in or around MCDs. Two of three patients with band heterotopia showed multiple increases in the overlying cortex. In three of four patients with subependymal nodular heterotopia, nodules had lower [11C]FMZ-Vd than the overlying cortex, which was normal. Decreases in [11C]FMZ-Vd were found in two of three clefts and one of six adjacent regions in one schizencephalic patient; another had normal [11C]FMZ-Vd in the thickened cortex itself but increases in all adjacent regions. Binding was reduced within focal cortical dysplasia but increased in adjacent cortex. [11C]FMZ-Vd was normal within one patient's polymicrogyric cortex but increased in one of six adjacent volumes of interest. The localization of abnormalities correlated with EEG and clinical data in cortical MCDs. Flumazenil binding was decreased in some MCDs with increased grey matter volume and increased in some adjacent or overlying areas of normal-appearing cortex, suggesting functional abnormalities beyond MRI- detectable structural changes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cereb CortexHome page
A. Croquelois, F. Giuliani, C. Savary, M. Kielar, C. Amiot, F. Schenk, and E. Welker
Characterization of the HeCo Mutant Mouse: A New Model of Subcortical Band Heterotopia Associated with Seizures and Behavioral Deficits
Cereb Cortex, June 18, 2008; (2008) bhn106v1.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Kato, E. Shimosegawa, N. Oku, K. Kitagawa, H. Kishima, Y. Saitoh, A. Kato, T. Yoshimine, and J. Hatazawa
MRI-Based Correction for Partial-Volume Effect Improves Detectability of Intractable Epileptogenic Foci on 123I-Iomazenil Brain SPECT Images
J. Nucl. Med., March 1, 2008; 49(3): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. Merlet, K. Ostrowsky, N. Costes, P. Ryvlin, J. Isnard, I. Faillenot, F. Lavenne, D. Dufournel, D. Le Bars, and F. Mauguiere
5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study
Brain, April 1, 2004; 127(4): 900 - 913.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, M. P. Richardson, R. Hurlemann, D. J. Brooks, and J. S. Duncan
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients
Brain, June 1, 2003; 126(6): 1300 - 1318.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. J. Rugg-Gunn, S. H. Eriksson, P. A. Boulby, M. R. Symms, G. J. Barker, and J. S. Duncan
Magnetization transfer imaging in focal epilepsy
Neurology, May 27, 2003; 60(10): 1638 - 1645.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Juhasz, D.C. Chugani, O. Muzik, A. Shah, E. Asano, T.J. Mangner, P.K. Chakraborty, S. Sood, and H.T. Chugani
Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy
Neurology, March 25, 2003; 60(6): 960 - 968.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
M. P Richardson
Epilepsy and surgical mapping
Br. Med. Bull., March 1, 2003; 65(1): 179 - 192.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. Frouin, C. Comtat, A. Reilhac, and M.-C. Gregoire
Correction of Partial-Volume Effect for PET Striatal Imaging: Fast Implementation and Study of Robustness
J. Nucl. Med., December 1, 2002; 43(12): 1715 - 1726.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, R. Hurlemann, M. Thom, M. P. Richardson, D. J. Brooks, and J. S. Duncan
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI
Brain, October 1, 2002; 125(10): 2257 - 2271.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.